Officials at Newsham Choice Genetics have announced that Groupe Grimaud, headquartered in France, will take over the U.S. genetics company as its full owner as of Feb. 1. The two copmany describe the move as "forwarding their commitment to become a global leader in providing swine genetics."
Newsham had been owned jointly by Groupe Grimaud's equity parent Bucolica of the Netherlands, the Mitchell family and some Newsham management personnel. According to Newsham's statement, the company considers itself to be the second-largest supplier of swine genetics in North America.
According to a Groupe Grimaud statement, it is the world's second-largest multi-species animal genetics company. It is involved principally in poultry breeding, through Hubbard for broiler chickens, Novogen for laying hens and Grimaud Frères for ducks. Groupe Grimaud also is developing technologies for biopharmaceutical use through Vivalis, its Euronext-listed subsidiary.
Frederic Grimaud, president of Groupe Grimaud, said about the Newsham development, "This ownership change indicates our dedication and support for the Newsham Choice Genetics business and its ability to create genetic change at an unprecedented rate to meet the demands of the swine industry. We also see a real opportunity to extend Newsham business worldwide through the global network of our group, as well as a larger cooperative emphasis in [research and development] innovation."
Newsham's headquarters is in Des Monies, Iowa, and the company's current management team will continue in their current roles.